CClinicalTrials.gg
Status unknownNCT01187940Updated Aug 24, 2010

Evaluating PEGASUS - a Group Intervention for Young People With an Autism Spectrum Disorder

An interventional study of PEGASUS in Efficacy of PEGASUS, sponsored by Institute of Child Health. Status unknown at 1 site in United Kingdom. Open to participants aged 9 Years to 14 Years. Per ClinicalTrials.gov, last updated 2010-08-24.

Sponsored by Institute of Child Health · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2010), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
9 Years to 14 Years
Sex
All
01

Study summary

When a clinician gives an autism spectrum disorder (ASD) diagnosis they hope this will be helpful to the person receiving it and their family. In reality children with an ASD describe few benefits to receiving this diagnosis - they often report feeling confused and stigmatised by it. Parents can also struggle to understand their child's diagnosis and report needing greater support from professionals in this respect (Midence \& O'neill, 1999; Osborne \& Reed, 2008).

Little is known about how to help children and families integrate their ASC 'label' in a positive way. Whilst there is anecdotal evidence that psychoeducation after diagnosis can help, there has been no formal evaluation of this approach and no evidence-based programmes of this type are available. In the current study the investigators aim to test empirically a psychoeducational programme for children with an ASD ('PEGASUS'), using a randomised controlled design. The investigators aim to evaluate whether this psychological and educational intervention impacts positively upon understanding of ASC, self-esteem, functional adaption, well-being and family functioning.

02

Conditions studied

  • Efficacy of PEGASUS

Keywords

  • Autism Spectrum Disorder;
  • Psychoeducation
03

In context

Autism Spectrum Disorder

1,727 studies on the registry are indexed under Autism Spectrum Disorder; 504 are open to participants now.

This study's planned enrollment of 40 is below the median of 52 across 1,371 interventional studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

Institute of Child Health is the lead sponsor of 40 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Received an ASD diagnosis from Child and Adolescent Psychiatrist, Clinical Psychologist or Paediatrician.
  2. Aware of ASD diagnosis.
  3. Aged between 9 and 14 years.
  4. Able to function in group setting, as evidenced in educational context.
  5. Speaks English

Exclusion criteria

Exclusion Criteria:

  1. No generalised Intellectual Disability as indicated by IQ below 65.
  2. Not engaged in additional formal psychosocial intervention during study period.
  3. Not taking psychiatric medication at baseline assessment, or taking a stable dose of psychiatric medication expected to remain constant throughout study participation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    PEGASUS

    PEGASUS - a psychoeducational group intervention with parallel parent and child sessions.

    Behavioral: PEGASUS

  • No intervention
    Placebo

    Will receive managment as usual from their local educational and NHS services

Interventions

  • BehavioralPEGASUS

    PEGASUS - a psychoeducational group intervention with parallel parent and child sessions.

06

What researchers measure

Primary outcomes

  1. Autism Knowledge Questionnaire

    All measures taken at baseline, termination of treatment and six months follow-up.

    Time frame: 30 months

  2. Child Behaviour Checklist

    All measures taken at baseline, termination of treatment and six months follow-up.

    Time frame: 30 months

  3. Vineland-II, Rosenburg Self-Esteem Scale

    All measures taken at baseline, termination of treatment and six months follow-up.

    Time frame: 30 months

  4. Parenting Stress index

    All measures taken at baseline, termination of treatment and six months follow-up.

    Time frame: 30 months

Secondary outcomes

  1. Qualitative interview conducted at baseline and termination.

    Time frame: 30 months

07

Study locations

1 site
  • Institute of Child Health
    London, WC1N 1EH, United Kingdom
    • William Mandy, dr · Contact · w.mandy@ucl.ac.uk
    • David Skuse, Professor · Principal investigator
08

References and documents

Publications

  • Gordon K, Murin M, Baykaner O, Roughan L, Livermore-Hardy V, Skuse D, Mandy W. A randomised controlled trial of PEGASUS, a psychoeducational programme for young people with high-functioning autism spectrum disorder. J Child Psychol Psychiatry. 2015 Apr;56(4):468-76. doi: 10.1111/jcpp.12304. Epub 2014 Aug 1. PubMed 25132516 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01187940
Lead sponsor
Institute of Child Health
First posted
Aug 24, 2010
Start date
Sep 2010
Primary completion
Sep 2012 (estimated)
Last update
Aug 24, 2010

Study contacts

William Mandy, Dr
Contact
w.mandy@ucl.ac.uk
William Mandy, Dr
study director · Institute of Child Health
David Skuse, Professor
principal investigator · Institute of Child Health

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion